NCT06639607 2026-03-10PRiME IIWashington University School of MedicinePhase 1/2 Not yet recruiting68 enrolled
NCT04238819 2026-03-02A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaEli Lilly and CompanyPhase 1/2 Completed47 enrolled 36 charts
NCT01026493 2017-07-02Veliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaRadiation Therapy Oncology GroupPhase 1/2 Completed257 enrolled 16 charts